Cilostazol USP Related Compound C
Synonyms: Cilostazol related compound C · Cilostazol Impurity 2
Cilostazol USP Related Compound C (CAS 865792-18-3) – Cilostazol impurity standard. C31H45N9O2, MW 575.7. Vaqora Chemicals: COA, global shipping.
About Cilostazol USP Related Compound C
Cilostazol USP Related Compound C is a pharmacopeial impurity of Cilostazol carrying the CAS registry number 865792-18-3. The compound has the formula C31H45N9O2, corresponding to a molecular weight of 575.7 g/mol. Its systematic (IUPAC) name is 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one. Common synonyms include Cilostazol related compound C and Cilostazol Impurity 2.
It is supplied as a solid. Store the standard in its sealed vial, protected from light and moisture, and follow the storage condition printed on the COA. Good laboratory practice and suitable PPE are recommended during handling.
As a characterised impurity of Cilostazol, it is used for analytical method development, method validation (AMV) and routine quality-control testing, and it supports ANDA and DMF regulatory filings. Buyers come mainly from pharmaceutical manufacturing and academic and industrial research.
Vaqora Chemicals supplies Cilostazol USP Related Compound C in 10 mg, 25 mg, 50 mg and 100 mg packs, each shipped with a Certificate of Analysis (COA), and exports worldwide.
Typical applications
- Pharmacopeial method verification
- Impurity profiling
- QC release testing
- ANDA / DMF filings
Industries
View every impurity, metabolite and intermediate we list for Cilostazol.
Cilostazol impuritiesGrade guides
Specifications & identifiers
| Product name | Cilostazol USP Related Compound C |
|---|---|
| Catalogue No. | VQ-021152 |
| CAS Number | 865792-18-3 |
| IUPAC name | 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one |
| Molecular formula | C31H45N9O2 |
| Molecular weight | 575.7 g/mol |
| Exact mass | 575.3696 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | GVMLJEUDNKNZAH-UHFFFAOYSA-N |
| SMILES | C1CCC(CC1)N2C(=NN=N2)CCCCN3C(=O)CCC4=C3C=CC(=C4)OCCCCC5=NN=NN5C6CCCCC6 |
| PubChem CID | 57643991 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | 5.3 |
| H-bond donors / acceptors | 0 / 8 |
| TPSA | 117 Ų |
Documents
Frequently asked questions
What is the CAS number of Cilostazol USP Related Compound C?
The CAS Registry Number of Cilostazol USP Related Compound C is 865792-18-3. It is also known as Cilostazol related compound C, Cilostazol Impurity 2.
What is the molecular formula and molecular weight of Cilostazol USP Related Compound C?
Cilostazol USP Related Compound C has the molecular formula C31H45N9O2 and a molecular weight of 575.7 g/mol. Its IUPAC name is 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one.
What is Cilostazol USP Related Compound C used for?
Cilostazol USP Related Compound C is supplied as a characterised reference material related to Cilostazol. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
Which grade and pack sizes of Cilostazol USP Related Compound C can I order?
We supply Cilostazol USP Related Compound C in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.
Do you provide a COA and SDS with Cilostazol USP Related Compound C?
Yes. Every lot of Cilostazol USP Related Compound C is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Can Cilostazol USP Related Compound C be shipped internationally?
Yes. We export Cilostazol USP Related Compound C worldwide by air and sea freight or express courier, on EXW, FOB, CIF, CFR or DAP Incoterms, with full export documentation.
Enquire about Cilostazol USP Related Compound C
We reply within one business day with price, pack options, lead time and documentation.